A Project Report for the partial fulfillment of the PGDF Course at SYMBIOSIS CENTRE OF MANAGEMENT and HUMAN RESOURCE DEVELOPMENT Submitted by Jayant Agarwal (PGDF-02) Table of Contents Sl no 1 2 2.1 2.2 3 3.1 3.2 4 5 5.1 5.2 6 7 7.1 7.2 7.3 8 8.1 8.2 8.3 8.4 8.5 8.6 8.7 9 9.1 9.2 10 11 Title Introduction Background of Ranbaxy Brief History Market share of Ranbaxy Background of Daiichi Sankyo Brief History
Premium Pharmaceutical industry Generic drug
Arby’s/Wendy’s Merger Triarc Companies Inc. is a holding company and‚ through one of the subsidiary Arby’s Restaurant Group Inc. is the franchisor of the Arby’s® restaurant system. Arby’s is the second largest restaurant franchising system in the sandwich segment of the quick service restaurant industry. As of June 29‚ 2008‚ there were a total of 3‚719 Arby’s restaurants in the system‚ including 1‚169 Company owned and 2‚550 franchised locations (Triarc‚ 2008). When Dave Thomas‚ founder of
Premium Nelson Peltz Internet Wendy's
MJacob Bliberg (jb3975@stern.nyu.edu) Jasper Buntinx (jasper@buntinx.eu) April 2013 Post-Acquisition Report Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) $6.8Bn acquisition of Cephalon‚ Inc. (NASDAQ: CEPH) – October 14‚ 2011 | Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) is a leading global pharmaceutical company which develops‚ produces and markets affordable generic drugs. Teva is the world’s largest generic drug maker‚ with a direct presence in about 60 countries. Teva’s
Premium Generic drug Takeover Pharmaceutical industry
Issues: » Study the synergies of the merger between Hindalco and Novelis » Study the rationale behind Hindalco acquiring a loss making aluminum company » Examine the way the acquisition deal was financed » Analyze whether the deal was overvalued or not » Analyze the trends in the global aluminum industry Keywords: Hindalco Industries Limited‚ Novelis Inc.‚ Merger and Acquisition‚ Deal Valuation‚ Debt-equity Ratio‚ EV/EBITDA Ratio‚ Indian Aluminum Industry‚ Merger Integration‚ Consolidation‚ Downstream
Premium Aditya Birla Group Birla family Kumar Mangalam Birla
1.1 Introduction Modern commercial banking‚ in its present form‚ is of recent origin. Though bank is considered to be an ancient institution just like money. Its evolution can be traced in the functions of money lender‚ the goldsmiths and the merchants. A bank has been often described as an institution engaged in accepting of deposits and granting loans. It can also be described as an institution which borrows idle resources‚ makes funds available to. It does not refer only to a place of tending
Premium Bank
Mergers & Acquisitions : Indian Banking Scenario Source - Banking Events Update (December 2004 issue) The Indian financial system would be open to intense international competition with complete implementation of the provisions of WTO agreement on services (GATS) during the year 2005-06 when banks will be required to compete across the globe with multinational banks having greater financial strengths. The banks will also be required to strengthen their capital position to meet stringent prudential
Premium Bank Mergers and acquisitions
PREPARED BY: HARYANTI HUSSEN (2009476958) BBA (HONS) FINANCE PREPARED FOR: PM MOHD ZAKI B. ZAKARIA TABLE OF CONTENT CHAPTER 1: INTRODUCTION 1.0 Background 1 1.1 Overview of CIMB Bank 2 1.2 Problem Statement 4 1.3 Research Objectives 4 1.4 Scope of the study 5 1.5 Limitation of the study 5 1.6 Significance of the study 6 1.7 Definition of term 7 CHAPTER 2: LITERATURE REVIEW
Premium Financial ratios Financial ratio Balance sheet
INDEX |EXECUTIVE SUMMARY |03 | |INTRODUCTION |04-05 | |OBJECTIVES |06 | |LITERATURE REVIEW
Premium Mutual fund Investment
A REPORT ON Ranbaxy-Daiichi Deal 1/26/2012 Ranbaxy-Daiichi Deal Introduction: Daiichi Sankyo bought Ranbaxy for $4.6 billion in June 2008. This report studies the implications of the merger between Ranbaxy and Daiichi Sankyo‚ from an intellectual property as well as a market point of view. There are many critical events happening in international pharma market including the growing preference for generics‚ increasing dominance of emerging markets such as India‚ fast approaching patent expiry
Premium Generic drug Ranbaxy Laboratories Pharmaceutical industry
The Failure of Mergers and Acquisitions Name Professor Institution Course Date THE FAILURE OF MERGERS AND QUISITIONS 2 RUNNING HEAD: THE FAILURE OF MERGERS AND QUISITIONS 1 The Failure of Mergers and Acquisitions Name Professor Institution Course Date The success of a any merger and acquisition is directly proportional to the level of planning that is involved. A lot of organisations do not spend enough time to
Premium Mergers and acquisitions Due diligence